Mindfulness-Based Relapse Prevention for Methadone Maintenance
Mindfulness-Based Relapse Prevention for Methadone Maintenance: A Feasibility Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Clearance from clinic staff
- Currently enrolled in a methadone maintenance program
- Agree to complete assessment questionnaires and attend treatment sessions
- Fluent in English
Exclusion Criteria:
- Indication of active psychosis
- Participation in past mindfulness-based relapse prevention group
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Mindfulness
Assigned to a 6-week mindfulness-based relapse prevention course
|
Psychosocial intervention integrating mindfulness practice and cognitive behavioral relapse prevention approaches
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability - Satisfaction with the Course
Time Frame: post course (6 weeks)
|
Satisfaction with the course will be assessed using the Overall Course Satisfaction Survey, items #1-4 (Bowen, Chawla, & Marlatt, 2010).
This is a self-report questionnaire, the first 4 items of which are open-ended questions assessing satisfaction with the course, barriers to learning, and perceived helpfulness.
|
post course (6 weeks)
|
|
Acceptability - Enactment of Learned Skills
Time Frame: post course (6 weeks)
|
Enactment will be assessed using the Overall Course Satisfaction Survey, items #5-7 (Bowen, Chawla, & Marlatt, 2010).
This is a self-report questionnaire, the last 3 questions of which are 10-point Likert-type items, and assess importance of skills and likelihood of implementing them into daily life after the course ends.
Higher scores indicate higher perceived importance and likelihood.
|
post course (6 weeks)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depression
Time Frame: 1 month
|
Depression symptoms will be assessed using the Beck Depression Inventory-II, a 21-item self report measure.
Items are summed for a total score ranging from 0-63.
A score of 0-13 is considered minimal range, 14-19 is mild, 20-28 is moderate, and 29-63 is severe.
|
1 month
|
|
Anxiety
Time Frame: 1 month
|
Anxiety symptoms will be assessed using the Beck Anxiety Inventory, a 21-item self report measure.
Items are summed for a total score that can range between 0 and 63 points.
A total score of 0 - 7 is interpreted as a Minimal anxiety, 8 - 15 as Mild, 16 - 25 as Moderate, and 26 - 63 as Severe.
|
1 month
|
|
Craving
Time Frame: 1 month
|
Craving for substances will be assessed using the Penn Alcohol Craving Scale, a five-item Likert-scaled measure assessing frequency, intensity, duration, and overall levels of craving, adapted to include both alcohol and drugs.
Each question is scaled from 0 to 6. Sum scores range from 0-30, with greater scores indicating higher craving.
|
1 month
|
|
Trauma symptoms
Time Frame: 1 month
|
PTSD symptoms will be assessed using the Post-Traumatic Stress Disorder Checklist-Civilian (PCL-C), which measures presence and severity of trauma symptoms using 16-item Likert-scaled questionnaire.
|
1 month
|
|
Experiential avoidance
Time Frame: 1 month
|
The Acceptance and Action Questionnaire (AAQ) is a widely used measure of experiential avoidance and psychological inflexibility consisting of nine Likert-scaled items, answer options ranging from 1 (never true) to 7 (always true).
High scores reflect greater experiential avoidance and immobility, while low scores reflect greater acceptance and action.
|
1 month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- MBRP for MMT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.